107 related articles for article (PubMed ID: 24528013)
1. Levels of serum 25-hydroxy-vitamin d in benign and malignant breast masses.
Alipour S; Hadji M; Hosseini L; Omranipour R; Saberi A; Seifollahi A; Bayani L; Shirzad N
Asian Pac J Cancer Prev; 2014; 15(1):129-32. PubMed ID: 24528013
[TBL] [Abstract][Full Text] [Related]
2. Low Levels of Vitamin D in a Cohort of Women with Impalpable Breast Lesions from Rio de Janeiro/Brazil.
Delmonico L; Costa MASM; Azevedo CM; Silvestre RT; Scherrer LR; Ornellas MHF; Alves G
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3087-3092. PubMed ID: 30485946
[TBL] [Abstract][Full Text] [Related]
3. Low pretreatment serum concentration of vitamin D at breast cancer diagnosis in postmenopausal women.
Machado MRM; de Sousa Almeida-Filho B; De Luca Vespoli H; Schmitt EB; Nahas-Neto J; Nahas EAP
Menopause; 2019 Mar; 26(3):293-299. PubMed ID: 30234730
[TBL] [Abstract][Full Text] [Related]
4. Patients With Invasive Ductal Carcinoma Have Reduced Levels of Decorin Expression in Their Breast Tissue Compared to Patients With Fibroadenoma While Plasma Decorin Remains Unchanged.
Falakian Z; Shahani T; Rezaie R; Mazloomzadeh S; Sirati F; Jalilvand A; Jahangiri F; Bahmani P; Jadali F; Atarian S; Eghdam-Zamir R; Biglari A
Arch Iran Med; 2018 Nov; 21(11):509-517. PubMed ID: 30551691
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of serum CA-15.3 in the management of benign breast lesion.
Mondal HP; Roy H; Mondal P; Saha M; Basu N
J Indian Med Assoc; 2012 Apr; 110(4):242-4. PubMed ID: 23025224
[TBL] [Abstract][Full Text] [Related]
6. Association between plasma 25-hydroxyvitamin D and breast cancer risk.
Crew KD; Gammon MD; Steck SE; Hershman DL; Cremers S; Dworakowski E; Shane E; Terry MB; Desai M; Teitelbaum SL; Neugut AI; Santella RM
Cancer Prev Res (Phila); 2009 Jun; 2(6):598-604. PubMed ID: 19470790
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor in Egyptian females with breast benign lumps and cancers.
El-Attar HA; Ragab MS; Sheta MI; Ahmed AS
Asian Pac J Cancer Prev; 2010; 11(4):893-6. PubMed ID: 21133597
[TBL] [Abstract][Full Text] [Related]
8. Low serum 25-hydroxy vitamin D levels are associated with aggressive breast cancer variants and poor prognostic factors in patients with breast carcinoma.
Karthikayan A; Sureshkumar S; Kadambari D; Vijayakumar C
Arch Endocrinol Metab; 2018 Aug; 62(4):452-459. PubMed ID: 30304110
[TBL] [Abstract][Full Text] [Related]
9. [A densitometric analysis of the chromatin structural characteristics of the nuclei in the peripheral blood lymphocytes of breast cancer patients].
Nalieskina LA
Tsitol Genet; 1995; 29(4):38-43. PubMed ID: 8604525
[TBL] [Abstract][Full Text] [Related]
10. Nutritional risk factors and status of serum 25(OH)D levels in patients with breast cancer: A case control study in India.
Sofi NY; Jain M; Kapil U; Seenu V; Kamal VK; Pandey RM
J Steroid Biochem Mol Biol; 2018 Jan; 175():55-59. PubMed ID: 27687737
[TBL] [Abstract][Full Text] [Related]
11. Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status.
Blackwell K; Haroon Z; Broadwater G; Berry D; Harris L; Iglehart JD; Dewhirst M; Greenberg C
J Clin Oncol; 2000 Feb; 18(3):600-8. PubMed ID: 10653875
[TBL] [Abstract][Full Text] [Related]
12. [Detection of serum CEA mRNA and CEA proteins in patients with breast cancer and its clinical significance].
Jin T; Chen DF; Gu LH
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):214-5. PubMed ID: 17649640
[No Abstract] [Full Text] [Related]
13. Prognostic Significance of Serum Vitamin D Levels in Egyptian Females with Breast Cancer.
Ismail A; El-Awady R; Mohamed G; Hussein M; Ramadan SS
Asian Pac J Cancer Prev; 2018 Feb; 19(2):571-576. PubMed ID: 29481024
[TBL] [Abstract][Full Text] [Related]
14. Calponin-h2: a potential serum marker for the early detection of human breast cancer?
Debald M; Jin JP; Linke A; Walgenbach KJ; Rauch P; Zellmer A; Fimmers R; Kuhn W; Hartmann G; Walgenbach-Brünagel G
Tumour Biol; 2014 Nov; 35(11):11121-7. PubMed ID: 25099617
[TBL] [Abstract][Full Text] [Related]
15. Clinical MR mammography: impact of hormonal status on background enhancement and diagnostic accuracy.
Baltzer PA; Dietzel M; Vag T; Burmeister H; Gajda M; Camara O; Pfleiderer SO; Kaiser WA
Rofo; 2011 May; 183(5):441-7. PubMed ID: 21318935
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D deficiency is associated with poor breast cancer prognostic features in postmenopausal women.
de Sousa Almeida-Filho B; De Luca Vespoli H; Pessoa EC; Machado M; Nahas-Neto J; Nahas EAP
J Steroid Biochem Mol Biol; 2017 Nov; 174():284-289. PubMed ID: 29031688
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of 25-hydroxy-vitamin D in patients with oral squamous cell carcinoma: Making a case for chemoprevention.
Udeabor SE; Albejadi AM; Al-Shehri WAK; Onwuka CI; Al-Fathani SY; Al Nazeh AA; Aldhahri SF; Alshahrani FA
Clin Exp Dent Res; 2020 Aug; 6(4):428-432. PubMed ID: 32246747
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D deficiency in patients admitted to the general ward with breast, lung, and colorectal cancer in Buenos Aires, Argentina.
Aguirre M; Manzano N; Salas Y; Angel M; Díaz-Couselo FA; Zylberman M
Arch Osteoporos; 2016; 11():4. PubMed ID: 26732091
[TBL] [Abstract][Full Text] [Related]
19. Fibroadenoma of the breast: analysis of associated pathological entities--a different risk marker in different age groups for concurrent breast cancer.
Shabtai M; Saavedra-Malinger P; Shabtai EL; Rosin D; Kuriansky J; Ravid-Megido M; Ben Haim M; Ayalon AH
Isr Med Assoc J; 2001 Nov; 3(11):813-7. PubMed ID: 11729575
[TBL] [Abstract][Full Text] [Related]
20. Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapy.
Jacot W; Pouderoux S; Thezenas S; Chapelle A; Bleuse JP; Romieu G; Lamy PJ
Breast Cancer Res Treat; 2012 Jul; 134(2):709-17. PubMed ID: 22562178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
